Centro de Imagem Diagnósticos S.A - Asset Resilience Ratio
Centro de Imagem Diagnósticos S.A (AALR3) has an Asset Resilience Ratio of 4.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore AALR3 total assets for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Centro de Imagem Diagnósticos S.A's Asset Resilience Ratio has changed over time. See AALR3 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Centro de Imagem Diagnósticos S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AALR3 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$96.94 Million | 3.2% |
| Short-term Investments | R$47.52 Million | 1.57% |
| Total Liquid Assets | R$144.46 Million | 4.77% |
Asset Resilience Insights
- Limited Liquidity: Centro de Imagem Diagnósticos S.A maintains only 4.77% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Centro de Imagem Diagnósticos S.A Industry Peers by Asset Resilience Ratio
Compare Centro de Imagem Diagnósticos S.A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
SMO ClinPlus Co. Ltd.
SHE:301257 |
Diagnostics & Research | 15.78% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Check-Cap Ltd.
NASDAQ:MBAI |
Diagnostics & Research | 2.90% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
Annual Asset Resilience Ratio for Centro de Imagem Diagnósticos S.A (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Centro de Imagem Diagnósticos S.A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.31% | R$124.54 Million ≈ $24.44 Million |
R$2.89 Billion ≈ $566.92 Million |
-2.75pp |
| 2023-12-31 | 7.06% | R$188.43 Million ≈ $36.97 Million |
R$2.67 Billion ≈ $523.87 Million |
+2.16pp |
| 2022-12-31 | 4.89% | R$128.02 Million ≈ $25.12 Million |
R$2.62 Billion ≈ $513.20 Million |
+0.64pp |
| 2021-12-31 | 4.26% | R$108.27 Million ≈ $21.24 Million |
R$2.54 Billion ≈ $498.83 Million |
-3.36pp |
| 2020-12-31 | 7.62% | R$193.64 Million ≈ $38.00 Million |
R$2.54 Billion ≈ $498.51 Million |
+4.55pp |
| 2019-12-31 | 3.07% | R$73.71 Million ≈ $14.46 Million |
R$2.40 Billion ≈ $471.14 Million |
-0.48pp |
| 2018-12-31 | 3.55% | R$78.44 Million ≈ $15.39 Million |
R$2.21 Billion ≈ $433.53 Million |
+1.97pp |
| 2017-12-31 | 1.58% | R$36.16 Million ≈ $7.10 Million |
R$2.28 Billion ≈ $448.36 Million |
-3.45pp |
| 2016-12-31 | 5.04% | R$109.10 Million ≈ $21.41 Million |
R$2.17 Billion ≈ $425.07 Million |
+4.80pp |
| 2015-12-31 | 0.24% | R$3.67 Million ≈ $720.51K |
R$1.54 Billion ≈ $301.46 Million |
-0.22pp |
| 2014-12-31 | 0.46% | R$6.71 Million ≈ $1.32 Million |
R$1.46 Billion ≈ $287.23 Million |
-- |
About Centro de Imagem Diagnósticos S.A
Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more